Generate Investment Management’s Novo Nordisk NVO Stock Holding History

Generate Investment Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.8M	Buy	+350,000	New	+$15M	0.69%	38
2025 Q4	–	Sell	-229,962	Closed	-$12.8M	–	94
2025 Q3	$12.8M	Buy	229,962 +69,423	+43%	+$4.06M	0.65%	43
2025 Q2	$11.1M	Buy	160,539 +120,577	+302%	+$8.2M	0.61%	47
2025 Q1	$2.77M	Hold	39,962	–	–	0.19%	74
2024 Q4	$3.44M	Hold	39,962	–	–	0.24%	75
2024 Q3	$4.76M	Sell	39,962 -108,401	-73%	-$14.5M	0.32%	69
2024 Q2	$21.2M	Sell	148,363 -2,881	-2%	-$382K	1.24%	21
2024 Q1	$19.4M	Buy	151,244 +3,490	+2%	+$415K	1.41%	20
2023 Q4	$15.3M	Buy	+147,754	New	+$14.6M	1.32%	26

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Generate Investment Management's NVO Position: Q2 2026 in Review

Generate Investment Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 350,000 shares worth $16.8M. The stake represents 0.69% of the portfolio and ranks #38 among its holdings. This is a return to the name: Generate Investment Management previously reported a position in NVO as recently as Q3 2025.

Generate Investment Management first reported a position in NVO in Q4 2023 and has held it in 9 quarters since. The position peaked at $21.2M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Generate Investment Management held 350,000 shares of Novo Nordisk worth $16.8M as of Q2 2026.
Novo Nordisk was a new Generate Investment Management position in Q2 2026.
Novo Nordisk made up 0.69% of Generate Investment Management's portfolio in Q2 2026, its #38 holding.
Generate Investment Management first reported a position in Novo Nordisk in Q4 2023 and has held it in 9 quarters since.
Generate Investment Management's Novo Nordisk position peaked at $21.2M in Q2 2024.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Generate Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.